TICAD8
Executive Summary

INTRODUCTION
TICAD 8 (Tunisia, August 27-28, 2022) was full of anomalies: COVID-19 limited the number ofconference attendees, the number of participating companies and exhibitions was limited, sideevents were online, and unfortunately, the Japanese Prime Minister was unable to attend. TICAD
VI, held in Kenya, had about 6,000 participants; this time, the number is about 2,000. However,small numbers do not necessarily mean that there are no results. I feel that Japan's uniqueapproach, which focuses on "people" and "quality," is steadily taking shape, and I believe that weshould continue to follow this path.
While Africa faces many challenges, such as excessive debt, environmental problems, fragile
infrastructure, and poverty, TICAD, under the pandemic, has renewed our awareness of theimportance of raising the level of health care. People's health creates the labor force, food andinfrastructure, leading to economic development. As the global economy and politics aredysfunctional due to COVID-19, African countries are being asked to be autonomous.
The African Development Association has realized and presented several projects that could help inthis regard. For more details, please read this report. But at the same time, these projects are justgetting started. We want to continue to grow these projects and spread their impact throughout
Africa, using Tunisia as a gateway.
Tetsuro YANO
President, AFRECO

p. 1

TICAD 8 ACTIVITIES IN TUNISIAINOUE BALLOON Workshop
In early spring of 2021, Toray Medical Co. Ltd. and Dr Kanji Inoue, the inventor of the INOUEBALLOON, shared their intention to make the INOUE BALLOON widely known throughout Africa
and to help save the lives of African people, especially pregnant women and unborn children. They
had worked in Kenya and Ethiopia to promote the INOUE BALLOON but expect to do so more
quickly and efficiently in Africa. AFRECO believes that the propagation of the INOUE BALLOON
would be in line with the idea of UHC, promoted by the Japanese government. Also, it would be agood idea to feature it at TICAD 8, and AFRECO has been lobbying the Ministry of Foreign Affairs,
the Embassy of Tunisia in Japan, the Embassy of Japan in Tunisia, and other related organizations.
As a result, with the support of JICA, Toray Medical and AFRECO organized an African medical
seminar from August 24 to 25 with Dr Habib Gamra (Prof. of Cardiology, Fattouma Bourguiba
University Hospital), a leading INOUE BALLOON specialist in Tunisia, as a partner. We invited
doctors from various countries to Fattouma Bourguiba University Hospital in Monastir, Tunisia, forthe training workshop and held lectures by Dr Inoue and Dr Gamra.
The African cardiology associations recommended 21 physicians from 18 countries whom they
thought could use the Inouye balloon immediately upon returning home after the workshop and itstechnology. But due to conflicts, visa issuance conditions, and passport theft, the finalists were from12 countries (Morocco, Senegal, Mali, Burkina Faso, Libya, Uganda, Kenya, Sudan, Niger,
Tanzania, Mauritania, and Cote d'Ivoire). In addition to observing the procedures performed by Dr
Inoue and Dr Gamra (4 cases on the first day and 3 cases on the second day), the participantslearned how the INOUE BALLOON works and experienced how to use the INOUE BALLOON while
using a model of a heart.
On the 25th, from 17:00, Dr Inoue gave a lecture on the history of INOUE BALLOON development
and Dr Gamra on complex cases of PTMC. In addition to the invited African physicians, theaudience consisted mainly of Tunisian cardiologists. During the discussion, many doctors
emphasized how many African people could be saved using the INOUE BALLOON. At the sametime, many doctors complained about the high price of the INOUE BALLOON for African people.
They also voiced the need for more training opportunities to use the INOUE BALLOON.
The training sessions and the lectures were streamed to the world via ZOOM. The viewers were not
only from Africa but also from Europe.
p. 2

In addition, the Tunisian Ministry of Health invited Dr Gamra to speak at "Investing in health inAFRICA, perspectives and challenges" on August 27 (The City of Culture, Tunis). Dr Gamra
presented the workshop and stressed the importance and necessity of the INOUE BALLOON.

＊The INOUE BALLOON is a type of catheter used in percutaneous transluminal mitral valvotomy(PTMC) to treat mitral stenosis caused by rheumatic fever or rheumatic heart disease. Rheumaticheart disease is still prevalent in Africa, and many young patients, especially women of childbearing
age, suffer from heart failure. About 60% of these patients have mitral stenosis, which PTMC has ahigh potential to save. In addition, PTMC is less physically demanding on the patient, and in mostcases, the patient can walk home the next day, allowing pregnant women to receive treatment withpeace of mind.
The INOUE BALLOON is produced and marketed by Toray Medical, Inc.

Press Conference
In cooperation with other stakeholders, AFRECO has been working on medical and health projects
that will benefit the people of Africa and take shape toward achieving UHC. Tunisia, in particular,
is an ideal partner for Japanese companies and organizations that wish to expand their businessand educational activities in Africa, both in terms of language and economy. To share Japaneseknow-how and technology with the Tunisian people and to work together to help Africa, especially
sub-Saharan Africa, the following four projects were developed and presented at the Sheraton Hotelin Tunis on August 26, 2012. At the beginning of the meeting, H.E. Mr Ali Marabet, Minister ofHealth, welcomed the participants and encouraged them to promote cooperation between the twocountries in health care.

1. Introduction of the INOUE BALLOON and workshop
The presentation's content will be the same as the INOUE BALLON workshop mentioned above.

2. First made in Tunisia, COVID-19 test kit production and sales
At the urging of the African Development Association and the Tunisian Chamber of Commerce andIndustry in Japan, G-Cube (a semiconductor engineering company based in Kobe, Japan) andp. 3

UNIMED (a pharmaceutical company based in Sousse, Tunisia) signed an MOU on June 14 tocollaborate in the field of manufacturing and marketing COVID-19 antigen and antibody test kits.
They agreed to develop test kits and medical devices not only for COVID-19 but also for otherendemic diseases in Africa.
For TICAD 8, they announced that NIPPOMED, a joint venture between the two companies, will beestablished on the UNIMED site. The goal is not only to transfer technology from Japan toNIPPOMED but also to use NIPPONMED as a base for the widespread dissemination ofpharmaceuticals and medical devices produced in Japan and Tunisia to African and Middle Eastcountries.
Taking advantage of TICAD8, G-Cube has concluded an MOU with the Tunisian PharmaceuticalIndustry Company (SIPHAT) for developing and producing functional foods using artichokes and isconsidering a joint venture with SIPHAT. In addition, there are talks with the Institute of Infectious
Diseases at El Manar University to conduct collaborative research with Nagoya University on
developing external diagnostic medicines for various infectious diseases and disorders.

3. Training of Bio Medical Engineers in Africa, with Tunisia as a hub
To train medical engineers in Tunisia in 2019, the African Development Association has signed an
MOU with the Higher Institute of Medical Technologies attached to El Manar University (ISTMT,Tunis, Tunisia) to cooperate in the establishment of a faculty. For Tunisia, which aims for advanced
medical care, training people who can maintain, manage, and adequately handle medicalequipment is not only an essential step but also necessary to lead sub-Saharan Africa in terms ofmedical care.
At TICAD 8, the Foundation for the International Promotion of Clinical Engineering (Tokyo), in thepresence of H.E. Shinsuke Shimizu, Ambassador of Japan to Tunisia, signed an MOU with ISTMT,promising to send lecturers to train engineers and cooperate in guiding local faculty. ISTMT is thefirst national university in Tunisia to offer Biomedical Engineering (BME) course.
On the occasion of TICAD 8, Morinomiya University of Medical Sciences, where Dr Tomotaka
Naramura and Dr Yoshihiro Tsuji, affiliated with the Foundation for the International Promotion ofClinical Engineering, teach, received a joint research request from NATURODETOX (Tunisia) toverify the effectiveness of their products.

p. 4

4. Toiletry product development for human resource development and creation of newindustries as part of the university exchange
Toa University (Yamaguchi) and Monastir University, through student exchange and online jointclasses, are working to improve sanitation in Africa:
Acquire hand-washing habits among children.
Assist with refugee camps.
Create local employment.
Educate entrepreneurship to develop Tunisian human resources and create new industries.
The company is working on the development of toiletry products.
As its first product, the company is developing a soap. It is mild to the skin and suitable for bothchildren and adults. It uses Tunisia's olive oil as the main ingredient, blended with precious prickly
pear cactus oil and natural essential oil from Tunisia. With an eye on the global palm oil problem(deforestation of tropical forests, decrease in wildlife), the company is also considering extracting
and blending Tunisian date oil as a raw material to replace palm oil.
Taking advantage of TICAD 8, they have contacted companies producing soap in Tunisia and will
work on soap production in earnest in the future.

MOU with Japanese Desk in Africa
The African Development Association signed an MOU with the Japanese Desk in Africa (JDA) atTICAD 8.
JDA was established in 2022 to support Japanese companies' business operations in Africa. JDA
consist of three companies: MK Development, a company with an extensive network and businessexperience in Sub-Saharan Africa; BDO, which provides auditing, advisory, accounting, and tax
services to both private and public sector organizations; and TRAVEL SUN, which provides
logistics, interpretation, translation, and event support for Japanese companies and individuals
travelling on business. JDA is an organization that supports Japanese companies to expand into
Tunisia and Africa by meeting the needs and expectations of Japanese companies with a deep
understanding and appreciation of Japanese culture and customs. The organization supports
Japanese companies in expanding their business in Tunisia and Africa. The press conference heldin Tunisia was also made possible with the cooperation of JDA.

p. 5

One of the JDA representatives, Hedi Ben Abbes, the president of the Tunisian-Japanese Chamberof Commerce and Industry (TJCCI), has allowed us to present to the association at every TJCCI
meeting since late 2021, resulting This led to the partnership between G-Cube and UNIMED.

Although it was too late for the press conference, the AI diagnostic system (developed by NTT Data
Group and Deeptek of India) by Qunie (Tokyo, Japan), which the JDA also introduced at the TJCCImeeting, will be tested at Abderrahmane Mami Ariana Hospital (Tunis, Tunisia). On the occasion ofTICAD 8, Knier received a request from JDA to support the establishment of a private hospital inTunisia and will continue to sift through the information as the country has the potential to become abase for the development of Japanese-style medical care. In addition, they will seek collaboration
with a Tunisian company that is developing the desert to promote the agriculture and livestockindustry and to introduce renewable energy.
In cooperation with JDA, we plan to introduce Japanese technology to Tunisia and, through Tunisia,
to sub-Saharan Africa.
*Click here for JDA URLhttps://japanesedeskinafrica.tn

Exchange of opinions with dignitaries
Due to various restrictions on the holding of TICAD8, AFRECO was not able to exchange opinionswith dignitaries as easily as at previous TICAD events. Still, on the other hand, we were able todiscuss various issues at length with those who could make appointments. We also met with key
figures from different countries at a dinner hosted by the Tunisian prime minister and a dinner
hosted by the Tunisian president.

p. 6

TICAD 8 OFFICIAL SIDE EVENT“How to Cooperate in the Health Sector in Africa Towards Universal
Health Coverage."
Organizers: Ministry of Finance, African Development Bank, AFRECO Supported by: Japan
International Cooperation Agency
The seminar was held online on August 25 at 21:00 JST based on the report "Survey on Japan's
Cooperation in the Health Sector in Africa(http://www.mof.go.jp/policy/international_policy/research/index.htm)," commissioned by the Ministryof Finance in 2021 and conducted by the African Development Association.
After a greeting by Mr Kentaro Ogata, Deputy Finance Minister of the Ministry of Finance, Tetsuya
Fukunaga, Counselor of the Association, gave an overview of the survey mentioned above. Jun
Hirabayashi, Director of Qunie, who surveyed with us, and Dr Naoyuki Kawahara, Representative ofRocinantes, a certified NPO, introduced Japan's technologies and products. Mr Mohan
Vivekanandan of the Development Bank of South Africa also spoke about how non-government
players in Africa can contribute to the achievement of UHC in Africa. The session was closed withwords from Mr Taku Hanajiri, Director of the African Development Bank Representative Office inAsia. Approximately 180 people viewed the event.

"Seeking a healthier and better life through drug discovery and the useof traditional African medicines."
Organized by: Kumamoto University, NPO Rocinantes
In collaboration with African educational institutions and other organizations, Kumamoto University
has been making various efforts to improve public health in Africa through the safe and secureutilization of traditional African medicines to help people lead healthier and better lives. In
recognition of these efforts, the African Development Association (ADA) opened the seminar on
September 20, starting at 16:00 Japan time, with the Kumamoto Proposal 2022, a new action plan
to resolve current issues, following on from the Kumamoto Proposal 2019.

p. 7